140 related articles for article (PubMed ID: 17008544)
1. CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover.
Orr SJ; Morgan NM; Elliott J; Burrows JF; Scott CJ; McVicar DW; Johnston JA
Blood; 2007 Feb; 109(3):1061-8. PubMed ID: 17008544
[TBL] [Abstract][Full Text] [Related]
2. SOCS3 targets Siglec 7 for proteasomal degradation and blocks Siglec 7-mediated responses.
Orr SJ; Morgan NM; Buick RJ; Boyd CR; Elliott J; Burrows JF; Jefferies CA; Crocker PR; Johnston JA
J Biol Chem; 2007 Feb; 282(6):3418-22. PubMed ID: 17138568
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated ITIMs enable ubiquitylation of an inhibitory cell surface receptor.
Walter RB; Häusermann P; Raden BW; Teckchandani AM; Kamikura DM; Bernstein ID; Cooper JA
Traffic; 2008 Feb; 9(2):267-79. PubMed ID: 18062779
[TBL] [Abstract][Full Text] [Related]
4. The sialoadhesin CD33 is a myeloid-specific inhibitory receptor.
Ulyanova T; Blasioli J; Woodford-Thomas TA; Thomas ML
Eur J Immunol; 1999 Nov; 29(11):3440-9. PubMed ID: 10556798
[TBL] [Abstract][Full Text] [Related]
5. The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2.
Taylor VC; Buckley CD; Douglas M; Cody AJ; Simmons DL; Freeman SD
J Biol Chem; 1999 Apr; 274(17):11505-12. PubMed ID: 10206955
[TBL] [Abstract][Full Text] [Related]
6. mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.
Yu Z; Maoui M; Wu L; Banville D; Shen S
Biochem J; 2001 Feb; 353(Pt 3):483-92. PubMed ID: 11171044
[TBL] [Abstract][Full Text] [Related]
7. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.
Whitney G; Wang S; Chang H; Cheng KY; Lu P; Zhou XD; Yang WP; McKinnon M; Longphre M
Eur J Biochem; 2001 Dec; 268(23):6083-96. PubMed ID: 11733002
[TBL] [Abstract][Full Text] [Related]
8. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
9. Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation.
Avril T; Freeman SD; Attrill H; Clarke RG; Crocker PR
J Biol Chem; 2005 May; 280(20):19843-51. PubMed ID: 15769739
[TBL] [Abstract][Full Text] [Related]
10. High glucose concentrations induce TNF-α production through the down-regulation of CD33 in primary human monocytes.
Gonzalez Y; Herrera MT; Soldevila G; Garcia-Garcia L; Fabián G; Pérez-Armendariz EM; Bobadilla K; Guzmán-Beltrán S; Sada E; Torres M
BMC Immunol; 2012 Apr; 13():19. PubMed ID: 22500980
[TBL] [Abstract][Full Text] [Related]
11. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.
Paul SP; Taylor LS; Stansbury EK; McVicar DW
Blood; 2000 Jul; 96(2):483-90. PubMed ID: 10887109
[TBL] [Abstract][Full Text] [Related]
12. ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2.
Walter RB; Raden BW; Zeng R; Häusermann P; Bernstein ID; Cooper JA
J Leukoc Biol; 2008 Jan; 83(1):200-11. PubMed ID: 17947393
[TBL] [Abstract][Full Text] [Related]
13. Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity.
Walter RB; Raden BW; Kamikura DM; Cooper JA; Bernstein ID
Blood; 2005 Feb; 105(3):1295-302. PubMed ID: 15454492
[TBL] [Abstract][Full Text] [Related]
14. Role of protein kinase C in the phosphorylation of CD33 (Siglec-3) and its effect on lectin activity.
Grobe K; Powell LD
Blood; 2002 May; 99(9):3188-96. PubMed ID: 11964282
[TBL] [Abstract][Full Text] [Related]
15. 3'-sialyllactose targets cell surface protein, SIGLEC-3, and induces megakaryocyte differentiation and apoptosis by lipid raft-dependent endocytosis.
Ha SH; Kwak CH; Park JY; Abekura F; Lee YC; Kim JS; Chung TW; Kim CH
Glycoconj J; 2020 Apr; 37(2):187-200. PubMed ID: 31900723
[TBL] [Abstract][Full Text] [Related]
16. OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily.
Patel N; Brinkman-Van der Linden EC; Altmann SW; Gish K; Balasubramanian S; Timans JC; Peterson D; Bell MP; Bazan JF; Varki A; Kastelein RA
J Biol Chem; 1999 Aug; 274(32):22729-38. PubMed ID: 10428856
[TBL] [Abstract][Full Text] [Related]
17. Roles of STAT3/SOCS3 pathway in regulating the visual function and ubiquitin-proteasome-dependent degradation of rhodopsin during retinal inflammation.
Ozawa Y; Nakao K; Kurihara T; Shimazaki T; Shimmura S; Ishida S; Yoshimura A; Tsubota K; Okano H
J Biol Chem; 2008 Sep; 283(36):24561-70. PubMed ID: 18614536
[TBL] [Abstract][Full Text] [Related]
18. SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis.
Orabona C; Pallotta MT; Volpi C; Fallarino F; Vacca C; Bianchi R; Belladonna ML; Fioretti MC; Grohmann U; Puccetti P
Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20828-33. PubMed ID: 19088199
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of leucocyte functions by CD33-related siglecs.
Avril T; Attrill H; Zhang J; Raper A; Crocker PR
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1024-7. PubMed ID: 17073742
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
Ikehara Y; Ikehara SK; Paulson JC
J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]